MedTrace Logo

Selenium and Immune Function

NCT00279812 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 133

Last updated 2018-07-16

Study results available
· View outcomes & findings →

Summary

The aim of the study is to investigate the relationship between dose and form of selenium on immune function, and to identify functional markers of selenium status.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

50ug selenium enriched yeast

Selenomethionine supplement (50ug/d Se) for 12 weeks

DIETARY_SUPPLEMENT

100ug selenium enriched yeast

Selenomethionine supplement (100ug/d Se) for 12 weeks

DIETARY_SUPPLEMENT

200ug selenium enriched yeast

Selenomethionine supplement (200ug/d Se) for 12 weeks

DIETARY_SUPPLEMENT

Control onion

3 meals per week containing un-enriched onion (4ug/d) for 12 weeks

DIETARY_SUPPLEMENT

Enriched onion

3 meals per week containing un-enriched onion (50ug/d) for 12 weeks

OTHER

Placebo

Placebo supplement for 12 weeks

Sponsors & Collaborators

  • Food Standards Agency, United Kingdom

    collaborator OTHER_GOV

  • Quadram Institute Bioscience

    lead OTHER

Principal Investigators

  • Susan J Fairweather-Tait, PhD · University of East Anglia

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-04-30
Primary Completion
2008-08-31
Completion
2008-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00279812 on ClinicalTrials.gov